(Q28202653)

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Osteoprotegerin mitigates tail suspension-induced osteopenia

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

A germinal center-like reaction in the nonlymphoid tissue of the synovial membrane

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Interleukin-18, rheumatoid arthritis, and tissue destruction

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen‐induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

1 reference

7 January 2021

The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

A proinflammatory role for IL-18 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Activated T lymphocytes support osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Functional CD40 ligand is expressed by T cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Collagen-induced arthritis, an animal model of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Therapeutic approaches to bone diseases

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

RANKing the importance of measles virus in Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Expression of osteoclast differentiation factor in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Efficacy and safety of leflunomide in active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

T Cell Activation Induces Human Osteoclast Formation via Receptor Activator of Nuclear Factor κB Ligand-Dependent and -Independent Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

Pathogenesis of rheumatoid arthritis: the role of synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900682-2

7 January 2021

10.1016/S8756-3282(01)00682-2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11856640

1 reference

Consolidated OpenCitations Corpus – April 2017